Journal Article Summary
The article investigates the long-term effects of administering allopurinol to pregnant women during labor when fetal hypoxia is suspected. This topic is significant because perinatal asphyxia can lead to serious complications, including cognitive disabilities and cerebral palsy in newborns. Allopurinol is thought to have neuroprotective properties that could potentially mitigate brain damage caused by hypoxia, but previous studies have primarily focused on short-term outcomes.
In this follow-up study, researchers evaluated children from the original ALLO-trial, where mothers were randomly assigned to receive either allopurinol or a placebo. At the age of five, the children's developmental and behavioral outcomes were assessed using two parent-reported questionnaires: the Ages and Stages Questionnaire (ASQ) and the Child Behavior Checklist (CBCL). The results showed no significant differences between the two groups; 15.1% of children in the allopurinol group and 9.2% in the placebo group scored abnormally on the ASQ, while 30.4% in the allopurinol group and 20% in the placebo group had abnormal scores on the CBCL.
The study has limitations, including a relatively low follow-up response rate of 62%, which may affect the reliability of the findings. Additionally, the study was underpowered, meaning it may not have had enough participants to detect a true difference if one existed. Patients and caregivers should discuss these findings with healthcare professionals, especially regarding the implications of allopurinol use during pregnancy and the management of fetal hypoxia, as ongoing research may provide further insights into effective treatments.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Klumper Job, Kaandorp Joepe J., Schuit Ewoud, Groenendaal Floris, Koopman-Esseboom Corine, Mulder Eduard J. H., Van Bel Frank, Benders Manon J. N. L., et al.. Behavioral and neurodevelopmental outcome of children after maternal allopurinol administration during suspected fetal hypoxia: 5-year follow up of the ALLO-trial. PLoS ONE 2018. DOI: 10.1371/journal.pone.0201063. PMID: 30138355. PMCID: PMC6107129.
Featured Pill Pals Product
Allopurinol 100 mg Tablets --- Generic For Zyloprim --- Unichem
Allopurinol 100 mg Tablets — Generic For Zyloprim — Unichem is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
